These findings align with previous studies linking MYBL2 to high Gleason scores and poor prognosis86 and RRM2 as a key driver of aggressive prostate cancer chromosomal instability of advanced-stage Pca61,62. The gene discussed is RRM2; the disease is prostate carcinoma.